Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BOTHELL, WA--(Marketwire - Nov 10, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, today reported financial results for the...
-
BOTHELL, WA--(Marketwire - Nov 2, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported significant reduction of microRNA-like...
-
BOTHELL, WA--(Marketwire - Oct 19, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it will present at The...
-
BOTHELL, WA--(Marketwire - Oct 19, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, reported in vivo dose-dependent efficacy with...
-
BOTHELL, WA--(Marketwire - Oct 17, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that it has entered into a...
-
BOTHELL, WA--(Marketwire - Sep 8, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it will present at the...
-
BOTHELL, WA--(Marketwire - Sep 7, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, today announced organizational changes that...
-
BOTHELL, WA--(Marketwire - Sep 1, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the U.S. Patent and...
-
BOTHELL, WA--(Marketwire - Aug 11, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNA-based drug discovery and development company, today reported financial results for the second quarter...
-
BOTHELL, WA--(Marketwire - Aug 10, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNA-based drug discovery and development company, reported in vivo data demonstrating up to 2.5-fold...